Skip to main content
. 2019 Apr 30;35(2):100–106. doi: 10.3393/ac.2018.10.01

Fig. 2.

Fig. 2.

Recurrence-free survival according to post-nCRT NLR using Kaplan-Meier analysis. Group with post-nCRT >5.21 showed lower 5-year RFS (69.2 vs. 76.7%, P = 0.038). nCRT, neoadjuvant chemoradiation therapy; NLR, neutrophil to lymphocyte ratio; RFS, recurrence-free survival.